Objective. To examine the associations of female reproductive and hormonal factors with incidence of total knee arthroplasty (TKA) for osteoarthritis (OA), and to determine whether the associations differ according to overweight/obesity status.
[95% confidence interval (95% CI) 1.06-1.63]). Parity was positively associated with risk of TKA (P for trend = 0.003). OC users had increased risk of TKA compared with non-users (for OC use of <5 years, HR 1.25 [95% CI 1.08-1.45]; for OC use of ≥5 years, HR 1.17 [95% CI 1.00-1.37]). A 1-year increase in menstruation was associated with a 1% decrease in risk of TKA (HR 0.99 [95% CI 0.97-0.99]). These associations remained significant only in women of normal weight at early reproductive age. Current HRT users had increased risk of TKA compared with non-users (HR 1.37 [95% CI 1.14-1.64]); the association was significant only in non-obese women at midlife.
Conclusion. Reproductive and hormonal factors were associated with risk of knee OA. These associations remained significant in women of normal weight at early reproductive age and in non-obese women at midlife. Further work is needed to understand the complex effect of these factors on knee OA.
Knee osteoarthritis (OA) is a prevalent disabling disease with multifactorial etiology including age, obesity, physical activity, malalignment, and genetics (1) . Women have a higher prevalence and incidence of knee OA than men after age 50 years (2) , suggesting a role for hormonal factors in the pathogenesis of OA. A number of studies have examined the association of reproductive and hormonal factors with knee OA, but the results are inconclusive. Increasing parity has been reported as a risk factor for radiographic knee OA and total knee arthroplasty (TKA) for OA (3, 4) , while other studies have found no association of parity with radiographic knee OA or TKA due to OA (5, 6) . A large prospective cohort study found increased risk of TKA associated with low age at menarche (6) , but this finding was contradicted by another large-scale cohort study showing no association (4) . No associations have been reported of the use of oral contraceptives (OCs) with knee cartilage volume (5) , radiographic knee OA (7), or TKA (4, 6) . While hormone replacement therapy (HRT) has been shown to be a protective factor for knee cartilage (8) and to protect against radiographic knee OA (9,10), other studies have found no association of HRT with knee pain due to OA (11) , with knee cartilage (12) , or with TKA (6, 13) . One study showed increased risk of TKA in relation to HRT (4) . These discrepant findings may be attributable to differences across studies in terms of evaluation criteria for OA (symptomatic, radiographic, or TKA), classification of exposures, study populations, and study designs.
A number of reproductive factors, such as menarche, parity, menopause, use of OCs, and HRT, are associated with obesity (14), a major risk factor for knee OA. For example, women gain weight and central body fat at the menopausal transition (15) . Thus, it is important to examine whether the associations of reproductive and hormonal factors with knee OA are modified and/or confounded by obesity, as obesity may influence the hormonal status of an individual (16) . This is of significant clinical and public health importance, given that there is no cure for knee OA and that we are faced with the global trend of increasing prevalence of knee OA and obesity.
Established cohorts, such as the Melbourne Collaborative Cohort Study (MCCS), provide an unprecedented opportunity to examine new hypotheses of OA pathogenesis involving sex steroid hormones, metabolic syndrome, index finger-to-ring finger length ratio, body weight trajectories, gene mutations, physical activity, ethnicity, and body adiposity. The MCCS was able to take advantage of this opportunity because of its communitybased recruitment of participants (which was completely independent of musculoskeletal disease), the long followup period, and the richness of prospectively collected data (17) . Using the MCCS data, we aimed to determine 1) whether reproductive factors (age at menarche, pregnancy, parity, duration of menstruation in years) and OC use increase the risk of TKA for OA, and whether the associations differ according to overweight status during early reproductive years (ages 18-21); and 2) whether menopause and HRT use increase the risk of TKA for OA, and whether the associations differ according to obesity status during midlife.
SUBJECTS AND METHODS
Study participants. The MCCS is a prospective cohort study of 41,514 participants (24,469 women) ages 27-75 years (99.3% were ages 40-69 years) recruited via the electoral roll, advertisements, and community announcements in local media in 1990-1994 (18) . Southern European migrants to Australia were deliberately oversampled to extend the range of lifestyle exposures and to increase genetic variation. The purpose of the study was to investigate prospectively the role of diet and other lifestyle factors in causing common chronic diseases (17) . The study protocol was approved by the Cancer Council Victoria Human Research Ethics Committee. Of the recruited participants, 4.8% were excluded because 1) they died or left Australia prior to January 1, 2001 ; 2) at the MCCS second follow-up visit, they had reported a primary joint replacement prior to January 1, 2001; or 3) their first recorded procedure was a revision joint replacement as recorded in the Australian Orthopaedic Association National Joint Replacement Registry (AOA NJRR). The current study examined data for 22,289 women.
Assessment of sociodemographic, comorbidity, and anthropometric data. At baseline, sociodemographic factors including date of birth, country of birth, smoking, physical activity during leisure time, education level, and physiciandiagnosed hypertension and diabetes mellitus were collected by face-to-face interviews. Height and weight were measured according to written protocols based on standard procedures. Body mass index (BMI) was calculated. Since the mean AE SD age of participants at baseline was 54.6 AE 8.6 years, weight and BMI at study entry were termed as weight and BMI at midlife. Participants were asked what their weight had been between ages 18 and 21 years (early reproductive age). These data were previously reported (19, 20) . Change in BMI from early reproductive age to midlife was calculated.
Assessment of reproductive and hormonal factors. At baseline, information was collected on age at menarche, ever being pregnant, number of live births (parity), menopausal status, age at menopause, and having had a hysterectomy or ovariectomy. Each woman was asked if she had ever taken HRT or OCs and, if so, for how long and whether they were current or previous users. Years of menstruation was calculated for women who experienced a natural menopause by deducting the age at menarche from the age at menopause.
Incidence of TKA for OA. The AOA NJRR collects information on prostheses, patient demographics, and type of and reason for arthroplasty. Data are collected from both public and private hospitals and validated using a sequential multilevel matching process against State and Territory Health Department unit record data. Following the validation process and retrieval of unreported records, the Registry collects an almost complete set of data relating to arthroplasties (>99%) in Australia (21) . This study examined the first knee arthroplasty with a contemporaneous diagnosis of OA, as recorded in the AOA NJRR. If one person had multiple arthroplasties, such as bilateral knee arthroplasties or both knee and hip arthroplasties, the first recorded procedure was considered the event. Matching of MCCS participants using first name, surname, date of birth, and sex to the AOA NJRR in order to identify those who had had an arthroplasty performed between January 1, 2001 and December 31, 2013 was done using the Freely Extensible Biomedical Record Linkage system. The linkage study was approved by the Human Research Ethics Committees of Cancer Council Victoria and Monash University. Knee OA was defined as the first recorded primary total joint arthroplasty that was a TKA for OA.
Statistical analysis. Cox proportional hazards regression models were used to estimate the hazard ratios (HRs) with 95% confidence intervals (95% CIs) for TKA associated with each individual reproductive and hormonal factor, with age as the time scale. BMI at midlife, change in BMI from early reproductive age to midlife, country of birth, physical activity, smoking, and education level were included in all models. Additional adjustment was done for comorbidities (hypertension [yes/no], diabetes mellitus [yes/no]). Follow-up for TKA (i.e., calculation of person-time) began January 1, 2001 and ended at the date of the first TKA for OA or at the date of censoring. Subjects were censored at the date of the first TKA performed for indications other than OA, the date of death, the date of leaving Australia, or the end of follow-up (December 31, 2013), whichever came first. Association of HRT use, duration of HRT use, age at menopause, and years of menstruation with TKA were analyzed only in women who experienced natural menopause at baseline and did not undergo an ovariectomy. To examine whether the relationship of reproductive factors and OCs with the risk of TKA for OA was modified by overweight status, stratified analysis was performed based on overweight status at early reproductive age (18-21 years) . Similarly, stratified analysis was performed based on obesity status at midlife to examine the association of age at menopause, years of menstruation, and HRT with risk of TKA. All these analyses were repeated in the subgroup of women who attended follow-up during [2004] [2005] [2006] [2007] (n = 15,828) with additional adjustment for change in BMI from midlife (1990) (1991) (1992) (1993) (1994) to 2004-2007 follow-up.
Tests based on Schoenfeld residuals and graphical methods using Kaplan-Meier curves showed no evidence that † Only those having natural menopause (n = 12,332). ‡ Only those having natural menopause and hormone replacement therapy (HRT) data not missing (n = 12,300 for HRT, n = 11,238 for duration of HRT).
proportional hazards assumptions were violated. All statistical analyses were performed using Stata 13.0 SE (StataCorp).
RESULTS
Over a mean AE SD 12.7 AE 2.9 years of follow-up, we identified 1,208 women with incident TKA for OA. Descriptive statistics of the participants' characteristics are shown in Table 1 . Women who received a TKA were older, had greater BMI at midlife and lower levels of education, were more likely to be overweight/obese during early reproductive life and obese at midlife, and were more likely to have been born in Australia/New Zealand than those who had had no joint replacement, while they were less likely to smoke. Those who had had a TKA were more likely to have been pregnant, to have higher parity, and to be postmenopausal; more of them were currently using HRT compared with those who had had no joint replacement. Table 2 shows reproductive and hormonal factors according to overweight status during early reproductive years, and menopausal status and HRT-related factors according to obesity status at midlife. Women who were overweight/obese at early reproductive age had an earlier onset of menarche and shorter duration of OC use compared with women of normal weight. Women who were obese at midlife were more likely to be postmenopausal, less likely to be current HRT users, and had shorter duration of HRT use compared with non-obese women.
The associations of reproductive and hormonal factors with risk of TKA are presented in Table 3 † Women who had been of normal weight at early reproductive age (n = 19,615) and postmenopausal women who were currently normal or overweight (n = 9,266). ‡ Women who had been overweight/obese at early reproductive age (n = 2,674) and postmenopausal women who were currently obese (n = 3,066). § Only those having natural menopause (n = 12,332). ¶ Only those having natural menopause and hormone replacement therapy (HRT) data not missing (n = 12,300 for HRT, n = 11,238 for duration of HRT).
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[95% CI 0.97-0.99]). All of these associations remained significant in women of normal weight at early reproductive age, but they were not significant in women who were overweight/obese despite the lower rate of TKA in the normal weight group compared with the overweight/obese group (5.2% versus 7.1%). No association was observed of age at menarche with TKA. Current HRT users had an increased risk of TKA compared with non-users (HR 1.37 [95% CI 1.14-1.64]). There was a linear association of increasing duration of HRT use with increased risk of TKA. Using never use of HRT as the reference, the adjusted HRs were 1.12 (95% CI 0.91-1.39) for HRT use of <1 year and HR 1.30 (95% CI 0.99-1.72) for HRT use of ≥1 year (P for trend = 0.03). All of the significant associations observed for the total population remained significant in those who were nonobese at midlife. There was a marginally significant association of HRT use with increased risk of TKA in the obese group (HR 1.38 [95% CI 0.99-1.92]). There was a trend toward a positive linear association of duration of HRT use with risk of TKA in non-obese women (P for trend = 0.06). The rate of TKA was lower in women who were normal/overweight at midlife than in women who were obese at midlife (4.0% versus 10.4%). No association was observed of age at menopause with TKA. Additional adjustment for comorbidities did not change the results (data not shown). Furthermore, we performed subgroup analysis with additional adjustment for change in BMI from midlife (1990) (1991) (1992) (1993) (1994) to 2004-2007 follow-up. The results were of a direction and magnitude similar to those of the total population as presented in Table 3 (see Supplementary Table 1 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10. 1002/art.40483/abstract).
DISCUSSION
Ever being pregnant, increasing parity, taking OCs, current HRT use, and longer duration of HRT use were associated with increased risk of TKA for * Adjusted for body mass index at midlife, change in body mass index (early to midlife), country of birth, education level, vigorous physical activity, and smoking status. HR = hazard ratio; 95% CI = 95% confidence interval; HRT = hormone replacement therapy. † Women who had been of normal weight at early reproductive age (n = 19,615) and postmenopausal women who were currently normal or overweight (n = 9,266). ‡ Women who had been overweight/obese at early reproductive age (n = 2,674) and postmenopausal women who were currently obese (n = 3,066).
OA, while prolonged years of menstruation was associated with reduced risk. In subgroup analyses, all the associations between reproductive factors and TKA remained significant for women of normal weight but not for overweight/obese women at early reproductive age. Similarly, current HRT use was associated with increased risk of TKA in non-obese women at midlife but not in obese women at midlife. No association was observed between age at menarche or age at menopause and TKA. Consistent with 2 previous studies (3,4), we found that pregnancy and parity increased the risk of TKA. This may have been due to weight gain during pregnancy and postpartum weight retention (3, 4) , which are common (22) . We found that women of normal weight gained more weight from early reproductive age to midlife compared with overweight/obese women. However, the association of pregnancy and parity with TKA was independent of BMI at midlife and independent of change in BMI from early reproductive age to midlife. In a subgroup analysis based on overweight status at early reproductive age (obesity is not common at this age), increased risk of TKA in relation to pregnancy and parity was seen in women of normal weight but not in overweight/obese women, despite a higher incidence of TKA in overweight/obese women. These findings suggest that the relationship of pregnancy and parity with TKA for OA is complex and may not simply be mediated through increased weight gain associated with pregnancy and parity.
While neither age at menarche nor age at menopause was associated with risk of TKA, increasing years of menstruation was associated with decreased risk of TKA for OA. This remained significant in women of normal weight in early reproductive life, but not in those who had been overweight/obese. There is no clear association between age at menarche and age at menopause, with studies showing direct association, inverse association, or no association (23) . Years of menstruation is a marker of prolonged reproductive life and active ovarian function (23) . Hormonal depletion at the end of the active reproductive period is linked to tissue damage and organ dysfunction (24) and to an increase in the risk of several diseases (25) (26) (27) . The results of our study suggest a protective effect of prolonged reproductive life on decreased risk of TKA.
Use of OCs increased the risk of TKA for OA in women of normal weight at early reproductive age, and current HRT use increased the risk of TKA for OA in women who were not obese in midlife. The relationship between reproductive hormone supplementation and knee OA is complex. Although greater exposure to estrogen may promote OA changes by increasing cartilage damage (28) , it is unclear whether hormone supplementation increases circulating sex hormone to levels sufficient to affect joint structure significantly. Among healthy women, HRT users have more knee cartilage volume than nonusers (8) . The effect of exogenous hormones (OCs and HRT) on joint health can be determined by many factors, including age at starting OCs, time elapsed from onset of menopause to starting HRT, and duration of HRT use.
We found that current HRT users started using HRT at an older age than past users (mean AE SD 53.9 AE 7.0 years versus 50.3 AE 7.5 years; P = 0.01). As the average age at onset of menopause in developed countries is 51 years (29) , these data suggest that past HRT users began HRT at menopausal transition, while current users began HRT~3 years after menopause. It may be that, analogous to other diseases (30, 31) , starting HRT later in menopause is associated with increased risk of knee OA. Alternatively, the association between HRT use and TKA may be due to nonbiologic factors, with women taking HRT having more access to health services, including TKA. However, we adjusted for confounders for TKA, and Australians have universal coverage so they can readily access TKA (32, 33) . Paradoxically, exposure to OCs increased the risk of knee OA but prolonged years of menstruation decreased the risk. Along with estrogen, other sex hormones might play a role in protecting women from knee OA development and progression. Prolonged years of menstruation increases exposure not only to estrogen but also to other endogenous sex hormones. The use of OCs might change the circulatory levels of endogenous hormones unfavorably, thus affecting joint health adversely. Further work will be needed to clarify this and the differences in OA outcomes based on the type of OC.
We observed significant associations of reproductive factors and taking OCs with the risk of TKA in women of normal weight but not in women who were overweight/obese at early reproductive ages, and of current HRT use with TKA in normal/overweight women but not in obese women at midlife. The underlying mechanism might be explained by the association of reproductive factors with obesity (34), inflammation (35) , and endothelial dysfunction (35, 36) . Overweight/obese women have already been exposed to increased mechanical loading and have inflammation and endothelial dysfunction, which are known risk factors for knee OA, due to excessive fat mass. This may mask any additional association of reproductive factors with TKA. If a person is obese, the excessive joint loading may be more likely to drive OA pathogenesis and progression. These findings suggest that the influence of reproductive and hormonal factors on the risk of TKA due to OA is complex and warrants further investigation.
Our results need to be considered within the study's limitations. We defined OA based on arthroplasty. Arthroplasty for OA may be influenced by factors such as access to health care, socioeconomic status, and patient preference, in addition to disease severity. This study was carried out in Australia where there is universal health coverage, so access to arthroplasty is available to all. Nevertheless, arthroplasty does reflect end-stage joint disease. We performed analysis with age as the time scale and adjusted for BMI at midlife, change in BMI (early to midlife), country of birth, education level, physical activity, smoking, and comorbidity. TKA was ascertained from the AOA NJRR. We did not have accurate arthroplasty data prior to 2001. This may have resulted in nondifferential misclassification of TKA.
Participants were asked at midlife (ages 40-69 years) to recall their weight at ages 18-21 years, which may have introduced bias by under-reporting of weight, especially by overweight and obese women (37) . However, we observed higher incidence of TKA in overweight/obese women at early reproductive age. In this study we examined weight at midlife (1990-1994, baseline) (38) . We repeated all the analyses in this subgroup adjusting for change in BMI from midlife (1990) (1991) (1992) (1993) (1994) to [2004] [2005] [2006] [2007] follow-up, and we found that the direction and magnitude of the results were similar to those of the total population. However, we could not adjust for weight history of entire life since weight was not measured repeatedly throughout life including at the time of pregnancy.
The self-reported reproductive and hormonal data were collected at baseline when the women included were middle-aged. Any misclassification would most likely have been nondifferential, resulting in underestimation of the associations. Reproductive history and OC use would not have changed, but HRT use and its duration might have changed during the follow-up. As duration of HRT use was associated with increased risk of TKA, not updating the duration of HRT may have resulted in an underestimation of the association. Although we do not have data on types of OCs, the combined OCs were most commonly used at that time (39) . It remains possible that residual confounding contributed to the association of hormonal factors with risk of TKA.
Ever being pregnant, increasing parity, OC use, current HRT use, and increasing duration of HRT use are risk factors for TKA due to OA, while prolonged years of menstruation decreases the risk. These findings add to the ongoing literature regarding the complex relationship of reproductive and hormonal factors with risk of knee OA. Given the huge burden of knee OA and associated TKA in women worldwide, further studies are needed to understand the complex association of reproductive factors with risk of knee OA, along with the role of obesity in this relationship.
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